Article | August 8, 2022

Leveraging Target Product Profiles To Optimize Portfolio Potential

How To Effectively Use Back Translation As A QA Tool For Clinical Trial Documents

Target product profiles (TPPs) are strategic development process tools that can be used to help enhance the development and commercialization of novel biopharmaceutical products. Incorporating a well-developed TPP into the product development decision-making process can decrease risk, accelerate approval, and help ensure product-market fit. And yet, less than 20 percent of FDA-approved products were developed using a TPP.

In this guide, we discuss the critical role of TPPs in product development and offer tips and best practices for integrating these tools into and across programs to optimize portfolio potential.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader